Post
The Wall Street Journal
wsj.com
did:plc:i3fhjvvkbmirhyu4aeihhrnv
While nearly 18% of U.S. adults have taken a GLP-1 drug for weight loss or to treat a chronic condition, about half of people will stop taking it within a year. Often, they don’t understand what is likely to come next.
Read more from Sumathi Reddy: 🔗 on.wsj.com/3ZBdRAW
2026-01-28T16:19:07.455Z